An announcement from Lexeo Therapeutics, Inc. (LXEO) is now available.
On March 11, 2024, Lexeo Therapeutics, Inc. secured a deal to privately place over 6 million shares at $15.13 each, aiming to raise approximately $95 million before fees. The proceeds are earmarked for general corporate purposes and working capital. The agreement includes registration rights, ensuring the resale of shares under specific conditions, and involves board-affiliated entities purchasing $6 million worth of shares. This strategic move is accompanied by a press release updating the company’s financial status, with the transaction hinging on customary closing conditions and relevant securities regulations.
For an in-depth examination of LXEO stock, go to TipRanks’ Stock Analysis page.